Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia.

Aldoss I, Mark L, Vrona J, Ramezani L, Weitz I, Mohrbacher AM, Douer D.

Ann Hematol. 2014 Nov;93(11):1839-43. doi: 10.1007/s00277-014-2124-y. Epub 2014 Jun 7.

PMID:
24906216
[PubMed - indexed for MEDLINE]
2.

Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia.

Douer D, Aldoss I, Lunning MA, Burke PW, Ramezani L, Mark L, Vrona J, Park JH, Tallman MS, Avramis VI, Pullarkat V, Mohrbacher AM.

J Clin Oncol. 2014 Mar 20;32(9):905-11. doi: 10.1200/JCO.2013.50.2708. Epub 2014 Feb 10.

PMID:
24516026
[PubMed - indexed for MEDLINE]
3.

An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemia.

Aldoss I, Pullarkat V, Patel R, Watkins K, Mohrbacher A, Levine AM, Douer D.

Med Oncol. 2013 Dec;30(4):744. doi: 10.1007/s12032-013-0744-z. Epub 2013 Oct 18.

PMID:
24135867
[PubMed - indexed for MEDLINE]
4.

Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma.

Jakubowiak AJ, Benson DM, Bensinger W, Siegel DS, Zimmerman TM, Mohrbacher A, Richardson PG, Afar DE, Singhal AK, Anderson KC.

J Clin Oncol. 2012 Jun 1;30(16):1960-5. doi: 10.1200/JCO.2011.37.7069. Epub 2012 Jan 30.

PMID:
22291084
[PubMed - indexed for MEDLINE]
Free Article
5.

A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma.

Zonder JA, Mohrbacher AF, Singhal S, van Rhee F, Bensinger WI, Ding H, Fry J, Afar DE, Singhal AK.

Blood. 2012 Jul 19;120(3):552-9. doi: 10.1182/blood-2011-06-360552. Epub 2011 Dec 19.

PMID:
22184404
[PubMed - indexed for MEDLINE]
Free Article
6.

Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.

Somlo G, Lashkari A, Bellamy W, Zimmerman TM, Tuscano JM, O'Donnell MR, Mohrbacher AF, Forman SJ, Frankel P, Chen HX, Doroshow JH, Gandara DR.

Br J Haematol. 2011 Aug;154(4):533-5. doi: 10.1111/j.1365-2141.2011.08623.x. Epub 2011 Apr 26. No abstract available.

PMID:
21517811
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation.

Bernstein I, Byun HM, Mohrbacher A, Douer D, Gorospe G 3rd, Hergesheimer J, Groshen S, O'Connell C, Yang AS.

Epigenetics. 2010 Nov-Dec;5(8):750-7. doi: 10.4161/epi.5.8.13105. Epub 2010 Nov 1.

PMID:
20861661
[PubMed - indexed for MEDLINE]
Free Article
8.

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma.

Reece DE, Sullivan D, Lonial S, Mohrbacher AF, Chatta G, Shustik C, Burris H 3rd, Venkatakrishnan K, Neuwirth R, Riordan WJ, Karol M, von Moltke LL, Acharya M, Zannikos P, Keith Stewart A.

Cancer Chemother Pharmacol. 2011 Jan;67(1):57-67. doi: 10.1007/s00280-010-1283-3. Epub 2010 Mar 20.

PMID:
20306195
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Therapy-related, mixed-lineage leukaemia translocation-positive, monoblastic myeloid sarcoma of the uterus.

Pullarkat V, Veliz L, Chang K, Mohrbacher A, Teotico AL, Forman SJ, Slovak ML.

J Clin Pathol. 2007 May;60(5):562-4.

PMID:
17513515
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

B cell non-Hodgkin's lymphoma: rituximab safety experience.

Mohrbacher A.

Arthritis Res Ther. 2005;7 Suppl 3:S19-25. Epub 2005 May 18. Review.

PMID:
15960818
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities.

Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH.

Transfusion. 2003 May;43(5):641-5.

PMID:
12702187
[PubMed - indexed for MEDLINE]
13.

Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study.

Mohrbacher AF, Gregory SA, Gabriel DA, Rusk JM, Giles FJ.

Cancer. 2002 May 15;94(10):2645-52.

PMID:
12173332
[PubMed - indexed for MEDLINE]
14.

Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications.

Nguyen TT, Mohrbacher AF, Tsai YC, Groffen J, Heisterkamp N, Nichols PW, Yu MC, Lübbert M, Jones PA.

Blood. 2000 May 1;95(9):2990-2.

PMID:
10779450
[PubMed - indexed for MEDLINE]
Free Article
15.

Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab.

Davis TA, White CA, Grillo-López AJ, Velásquez WS, Link B, Maloney DG, Dillman RO, Williams ME, Mohrbacher A, Weaver R, Dowden S, Levy R.

J Clin Oncol. 1999 Jun;17(6):1851-7.

PMID:
10561225
[PubMed - indexed for MEDLINE]
16.

The influence of patient-related factors on ex vivo retroviral-mediated gene transfer into mobilized peripheral blood myeloid progenitors.

Douer D, Ramezani L, Mohrbacher AF, Khan A, Groshen S, Levine AM, Anderson WF.

Hum Gene Ther. 1998 May 1;9(7):1061-8.

PMID:
9607417
[PubMed - indexed for MEDLINE]
17.

High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults.

Douer D, Levine A, Anderson WF, Gordon M, Groshen S, Khan A, Mohrbacher A, Muggia F, Shibata D.

Hum Gene Ther. 1996 Mar 20;7(5):669-84. No abstract available.

PMID:
8845392
[PubMed - indexed for MEDLINE]
18.

Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.

Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC.

Blood. 1993 Dec 15;82(12):3712-20.

PMID:
8260708
[PubMed - indexed for MEDLINE]
Free Article
19.

Regulation of c-jun gene expression in human T lymphocytes.

Chauhan D, Kharbanda SM, Rubin E, Barut BA, Mohrbacher A, Kufe DW, Anderson KC.

Blood. 1993 Mar 15;81(6):1540-8.

PMID:
8453101
[PubMed - indexed for MEDLINE]
Free Article
20.

Role of interleukin 6 in the growth of myeloma-derived cell lines.

Barut BA, Zon LI, Cochran MK, Paul SR, Chauhan D, Mohrbacher A, Fingeroth J, Anderson KC.

Leuk Res. 1992 Oct;16(10):951-9.

PMID:
1405708
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk